TC

Thomas R. Coolidge

AP Amylin Pharmaceuticals: 11 patents #14 of 151Top 10%
BI Bionebraska: 9 patents #4 of 25Top 20%
UN University Of Nebraska: 4 patents #92 of 808Top 15%
AL Astrazeneca Pharmaceuticals Lp: 1 patents #40 of 76Top 55%
📍 Falls Village, CT: #1 of 10 inventorsTop 10%
🗺 Connecticut: #1,653 of 34,797 inventorsTop 5%
Overall (All Time): #185,704 of 4,157,543Top 5%
23
Patents All Time

Issued Patents All Time

Showing 1–23 of 23 patents

Patent #TitleCo-InventorsDate
8551947 Treatment of hibernating myocardium with an exendin peptide Mario Ehlers 2013-10-08
7981861 Method of performing angioplasty with a GLP-1 molecule Mario Ehlers 2011-07-19
7888314 Compositions and methods for treating peripheral vascular disease David R. Hathaway 2011-02-15
RE41288 Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain Mario Ehlers 2010-04-27
7265087 Exendin improves β-cell response in subjects with impaired glucose tolerance Burkhard J. Göke, Maria Byrne 2007-09-04
7259136 Compositions and methods for treating peripheral vascular disease David R. Hathaway 2007-08-21
7056887 Treatment of acute coronary syndrome with GLP-1 Mario Ehlers 2006-06-06
6998387 Human appetite control by glucagon-like peptide receptor binding compounds Burkhard J. Göke, Christoph Beglinger 2006-02-14
6982248 Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue Mario Ehlers 2006-01-03
6894024 Treatment of hibernating myocardium and diabetic cardiomyopathy with a GLP-1 peptide Mario Ehlers 2005-05-17
6706689 Treatment of acute coronary syndrome with GLP-1 Mario Ehlers 2004-03-16
6429197 Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain Mario Ehlers 2002-08-06
6284725 Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue Mario Ehlers 2001-09-04
6127150 Purification cloning of peptides Fred W. Wagner, Gino Van Heeke, Sheldon M. Schuster, Jay Stout, Dwane E. Wylie 2000-10-03
5741686 Exopeptidase catalyzed site-specific bonding of supports, labels and bioactive agents to proteins Fred W. Wagner, Dwane E. Wylie, Sheldon M. Schuster, William J. Lewis, Jay Stout 1998-04-21
5700775 Method and treatment composition for decreasing patient time in catabolic state after traumatic injury Mark Gutniak, Robert R. Recker, Fred W. Wagner 1997-12-23
5656456 Chemical method for selective modification of the N- and/or C-terminal amino acid .alpha.-carbon reactive group of a recombinant polypeptide or a portion thereof Jay Stout, Fred W. Wagner, Bart Holmquist 1997-08-12
5635371 Chemical method for selective modification of the N- and/or C-terminal amino acid .alpha.-carbon reactive group of a recombinant polypeptide or a portion thereof Jay Stout, Fred W. Wagner, Bart Holmquist 1997-06-03
5595887 Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment Fred W. Wagner, Gino Van Heeke, Sheldon M. Schuster, Jay Stout, Dwane E. Wylie 1997-01-21
5464759 Sequential oligonucleotide syntheses using immunoaffinity techniques William J. Lewis, Sheldon M. Schuster, Jay Stout, Gino Van Heeke, Dwane E. Wylie +1 more 1995-11-07
5279954 Exopeptidase catalyzed site-specific bonding of supports, labels and bioactive agents to proteins Fred W. Wagner, Dwane E. Wylie, Sheldon M. Schuster, William J. Lewis, Jay Stout 1994-01-18
5234820 Exopeptidase catalyzed site-specific bonding of supports, labels and bioactive agents to proteins Fred W. Wagner, Sheldon M. Schuster, Jay Stout, Dwane E. Wylie, Klaus Breddam +1 more 1993-08-10
5221736 Sequential peptide and oligonucleotide syntheses using immunoaffinity techniques William J. Lewis, Sheldon M. Schuster, Dwane E. Wylie, Fred W. Wagner, Jay Stout +1 more 1993-06-22